Index by author

September 2007; Volume 2,Issue 5

Looking for COVID information? All ASN Journal COVID articles are in the COVID-19 Research Collection or the COVID-19 In Context Collection. All articles are free.​

A

  1. Adams-Huet, Beverley

    1. Low Urine pH: A Novel Feature of the Metabolic Syndrome
      Naim M. Maalouf, Mary Ann Cameron, Orson W. Moe, Beverley Adams-Huet and Khashayar Sakhaee
      CJASN September 2007, 2 (5) 883-888; DOI: https://doi.org/10.2215/CJN.00670207

  2. Ahmadzadeh, Shahram

    1. Obesity Is Associated with Secondary Hyperparathyroidism in Men with Moderate and Severe Chronic Kidney Disease
      Csaba P. Kovesdy, Shahram Ahmadzadeh, John E. Anderson and Kamyar Kalantar-Zadeh
      CJASN September 2007, 2 (5) 1024-1029; DOI: https://doi.org/10.2215/CJN.01970507

  3. Ahmed, Sofia B.

    1. Gender and the Renal Nitric Oxide Synthase System in Healthy Humans
      Sofia B. Ahmed, Naomi D.L. Fisher and Norman K. Hollenberg
      CJASN September 2007, 2 (5) 926-931; DOI: https://doi.org/10.2215/CJN.00110107

  4. Akalin, Enver

    1. Routine Use of Ambulatory Blood Pressure Monitoring in Potential Living Kidney Donors
      Elizabeth S. Ommen, Bernd Schröppel, Jin-Yon Kim, Gabrielle Gaspard, Enver Akalin, Graciella de Boccardo, Vinita Sehgal, Michael Lipkowitz and Barbara Murphy
      CJASN September 2007, 2 (5) 1030-1036; DOI: https://doi.org/10.2215/CJN.01240307

  5. Albizem, Moetaz

    1. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview
      Glenn M. Chertow, Lara B. Pupim, Geoffrey A. Block, Ricardo Correa-Rotter, Tilman B. Drueke, Jürgen Floege, William G. Goodman, Gerard M. London, Kenneth W. Mahaffey, Sharon M. Moe, David C. Wheeler, Moetaz Albizem, Kurt Olson, Preston Klassen and Patrick Parfrey
      CJASN September 2007, 2 (5) 898-905; DOI: https://doi.org/10.2215/CJN.04381206

  6. Alpers, Charles E.

    1. Spectrum of Renal Pathology in Hematopoietic Cell Transplantation: A Series of 20 Patients and Review of the Literature
      Anthony Chang, Sangeeta Hingorani, Jolanta Kowalewska, Mary E.D. Flowers, Tia Aneja, Kelly D. Smith, Shane M. Meehan, Roberto F. Nicosia and Charles E. Alpers
      CJASN September 2007, 2 (5) 1014-1023; DOI: https://doi.org/10.2215/CJN.01700407

  7. Alvestrand, Anders

    1. Plasma Pentraxin 3 in Patients with Chronic Kidney Disease: Associations with Renal Function, Protein-Energy Wasting, Cardiovascular Disease, and Mortality
      Mengli Tong, Juan Jesús Carrero, A. Rashid Qureshi, Björn Anderstam, Olof Heimbürger, Peter Bárány, Jonas Axelsson, Anders Alvestrand, Peter Stenvinkel, Bengt Lindholm and Mohamed E. Suliman
      CJASN September 2007, 2 (5) 889-897; DOI: https://doi.org/10.2215/CJN.00870207

  8. Anderson, John E.

    1. Obesity Is Associated with Secondary Hyperparathyroidism in Men with Moderate and Severe Chronic Kidney Disease
      Csaba P. Kovesdy, Shahram Ahmadzadeh, John E. Anderson and Kamyar Kalantar-Zadeh
      CJASN September 2007, 2 (5) 1024-1029; DOI: https://doi.org/10.2215/CJN.01970507

  9. Anderstam, Björn

    1. Plasma Pentraxin 3 in Patients with Chronic Kidney Disease: Associations with Renal Function, Protein-Energy Wasting, Cardiovascular Disease, and Mortality
      Mengli Tong, Juan Jesús Carrero, A. Rashid Qureshi, Björn Anderstam, Olof Heimbürger, Peter Bárány, Jonas Axelsson, Anders Alvestrand, Peter Stenvinkel, Bengt Lindholm and Mohamed E. Suliman
      CJASN September 2007, 2 (5) 889-897; DOI: https://doi.org/10.2215/CJN.00870207

  10. Aneja, Tia

    1. Spectrum of Renal Pathology in Hematopoietic Cell Transplantation: A Series of 20 Patients and Review of the Literature
      Anthony Chang, Sangeeta Hingorani, Jolanta Kowalewska, Mary E.D. Flowers, Tia Aneja, Kelly D. Smith, Shane M. Meehan, Roberto F. Nicosia and Charles E. Alpers
      CJASN September 2007, 2 (5) 1014-1023; DOI: https://doi.org/10.2215/CJN.01700407

  11. Arnold, Robert M.

    1. Renal Provider Recognition of Symptoms in Patients on Maintenance Hemodialysis
      Steven D. Weisbord, Linda F. Fried, Maria K. Mor, Abby L. Resnick, Mark L. Unruh, Paul M. Palevsky, David J. Levenson, Stephen H. Cooksey, Michael J. Fine, Paul L. Kimmel and Robert M. Arnold
      CJASN September 2007, 2 (5) 960-967; DOI: https://doi.org/10.2215/CJN.00990207

  12. Avino, Deborah

    1. Stability of Target Hemoglobin Levels during the First Year of Epoetin Treatment in Patients with Chronic Kidney Disease
      Luca De Nicola, Giuseppe Conte, Paolo Chiodini, Bruno Cianciaruso, Andrea Pota, Vincenzo Bellizzi, Giuseppina Tirino, Deborah Avino, Fausta Catapano and Roberto Minutolo
      CJASN September 2007, 2 (5) 938-946; DOI: https://doi.org/10.2215/CJN.01690407

  13. Axelsson, Jonas

    1. Plasma Pentraxin 3 in Patients with Chronic Kidney Disease: Associations with Renal Function, Protein-Energy Wasting, Cardiovascular Disease, and Mortality
      Mengli Tong, Juan Jesús Carrero, A. Rashid Qureshi, Björn Anderstam, Olof Heimbürger, Peter Bárány, Jonas Axelsson, Anders Alvestrand, Peter Stenvinkel, Bengt Lindholm and Mohamed E. Suliman
      CJASN September 2007, 2 (5) 889-897; DOI: https://doi.org/10.2215/CJN.00870207

  14. Azizi, Fereidoun

    1. Are Patients Who Have Metabolic Syndrome without Diabetes at Risk for Developing Chronic Kidney Disease? Evidence Based on Data from a Large Cohort Screening Population
      Arash Rashidi, Arash Ghanbarian and Fereidoun Azizi
      CJASN September 2007, 2 (5) 976-983; DOI: https://doi.org/10.2215/CJN.01020207

  15. Azizi, Michel

    1. Hormonal and Hemodynamic Effects of Aliskiren and Valsartan and Their Combination in Sodium-Replete Normotensive Individuals
      Michel Azizi, Joël Ménard, Alvine Bissery, Than-Tam Guyene and Alessandra Bura-Rivière
      CJASN September 2007, 2 (5) 947-955; DOI: https://doi.org/10.2215/CJN.00360107

B

  1. Bárány, Peter

    1. Plasma Pentraxin 3 in Patients with Chronic Kidney Disease: Associations with Renal Function, Protein-Energy Wasting, Cardiovascular Disease, and Mortality
      Mengli Tong, Juan Jesús Carrero, A. Rashid Qureshi, Björn Anderstam, Olof Heimbürger, Peter Bárány, Jonas Axelsson, Anders Alvestrand, Peter Stenvinkel, Bengt Lindholm and Mohamed E. Suliman
      CJASN September 2007, 2 (5) 889-897; DOI: https://doi.org/10.2215/CJN.00870207

  2. Beddhu, Srinivasan

    1. Associations of Body Size with Metabolic Syndrome and Mortality in Moderate Chronic Kidney Disease
      Bonnie C.H. Kwan, Maureen A. Murtaugh and Srinivasan Beddhu
      CJASN September 2007, 2 (5) 992-998; DOI: https://doi.org/10.2215/CJN.04221206

  3. Belfiglio, Maurizio

    1. Identifying Patients at Risk for Microalbuminuria via Interaction of the Components of the Metabolic Syndrome: A Cross-Sectional Analytic Study
      Monica Franciosi, Fabio Pellegrini, Michele Sacco, Giorgia De Berardis, Maria C.E. Rossi, Giovanni F.M. Strippoli, Maurizio Belfiglio, Gianni Tognoni, Miriam Valentini, Antonio Nicolucci and ; on behalf of the IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group
      CJASN September 2007, 2 (5) 984-991; DOI: https://doi.org/10.2215/CJN.01190307

  4. Bellizzi, Vincenzo

    1. Stability of Target Hemoglobin Levels during the First Year of Epoetin Treatment in Patients with Chronic Kidney Disease
      Luca De Nicola, Giuseppe Conte, Paolo Chiodini, Bruno Cianciaruso, Andrea Pota, Vincenzo Bellizzi, Giuseppina Tirino, Deborah Avino, Fausta Catapano and Roberto Minutolo
      CJASN September 2007, 2 (5) 938-946; DOI: https://doi.org/10.2215/CJN.01690407

  5. Bissery, Alvine

    1. Hormonal and Hemodynamic Effects of Aliskiren and Valsartan and Their Combination in Sodium-Replete Normotensive Individuals
      Michel Azizi, Joël Ménard, Alvine Bissery, Than-Tam Guyene and Alessandra Bura-Rivière
      CJASN September 2007, 2 (5) 947-955; DOI: https://doi.org/10.2215/CJN.00360107

  6. Bleyer, Anthony J.

    1. Use of Antimicrobial Catheter Lock Solutions to Prevent Catheter-Related Bacteremia
      Anthony J. Bleyer
      CJASN September 2007, 2 (5) 1073-1078; DOI: https://doi.org/10.2215/CJN.00290107

  7. Block, Geoffrey A.

    1. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview
      Glenn M. Chertow, Lara B. Pupim, Geoffrey A. Block, Ricardo Correa-Rotter, Tilman B. Drueke, Jürgen Floege, William G. Goodman, Gerard M. London, Kenneth W. Mahaffey, Sharon M. Moe, David C. Wheeler, Moetaz Albizem, Kurt Olson, Preston Klassen and Patrick Parfrey
      CJASN September 2007, 2 (5) 898-905; DOI: https://doi.org/10.2215/CJN.04381206

  8. Bloom, Roy D.

    1. Therapeutic Drug Monitoring of Mycophenolic Acid
      Leslie M. Shaw, Michal Figurski, Michael C. Milone, Jennifer Trofe and Roy D. Bloom
      CJASN September 2007, 2 (5) 1062-1072; DOI: https://doi.org/10.2215/CJN.03861106

  9. Branton, Mary H.

    1. Pirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis
      Monique E. Cho, David C. Smith, Mary H. Branton, Scott R. Penzak and Jeffrey B. Kopp
      CJASN September 2007, 2 (5) 906-913; DOI: https://doi.org/10.2215/CJN.01050207

  10. Bura-Rivière, Alessandra

    1. Hormonal and Hemodynamic Effects of Aliskiren and Valsartan and Their Combination in Sodium-Replete Normotensive Individuals
      Michel Azizi, Joël Ménard, Alvine Bissery, Than-Tam Guyene and Alessandra Bura-Rivière
      CJASN September 2007, 2 (5) 947-955; DOI: https://doi.org/10.2215/CJN.00360107

C

  1. Cameron, Mary Ann

    1. Low Urine pH: A Novel Feature of the Metabolic Syndrome
      Naim M. Maalouf, Mary Ann Cameron, Orson W. Moe, Beverley Adams-Huet and Khashayar Sakhaee
      CJASN September 2007, 2 (5) 883-888; DOI: https://doi.org/10.2215/CJN.00670207

  2. Carrero, Juan Jesús

    1. Plasma Pentraxin 3 in Patients with Chronic Kidney Disease: Associations with Renal Function, Protein-Energy Wasting, Cardiovascular Disease, and Mortality
      Mengli Tong, Juan Jesús Carrero, A. Rashid Qureshi, Björn Anderstam, Olof Heimbürger, Peter Bárány, Jonas Axelsson, Anders Alvestrand, Peter Stenvinkel, Bengt Lindholm and Mohamed E. Suliman
      CJASN September 2007, 2 (5) 889-897; DOI: https://doi.org/10.2215/CJN.00870207

  3. Catapano, Fausta

    1. Stability of Target Hemoglobin Levels during the First Year of Epoetin Treatment in Patients with Chronic Kidney Disease
      Luca De Nicola, Giuseppe Conte, Paolo Chiodini, Bruno Cianciaruso, Andrea Pota, Vincenzo Bellizzi, Giuseppina Tirino, Deborah Avino, Fausta Catapano and Roberto Minutolo
      CJASN September 2007, 2 (5) 938-946; DOI: https://doi.org/10.2215/CJN.01690407

  4. Chang, Anthony

    1. Spectrum of Renal Pathology in Hematopoietic Cell Transplantation: A Series of 20 Patients and Review of the Literature
      Anthony Chang, Sangeeta Hingorani, Jolanta Kowalewska, Mary E.D. Flowers, Tia Aneja, Kelly D. Smith, Shane M. Meehan, Roberto F. Nicosia and Charles E. Alpers
      CJASN September 2007, 2 (5) 1014-1023; DOI: https://doi.org/10.2215/CJN.01700407

  5. Chertow, Glenn M.

    1. Rise of Pay for Performance: Implications for Care of People with Chronic Kidney Disease
      Amar A. Desai, Alan M. Garber and Glenn M. Chertow
      CJASN September 2007, 2 (5) 1087-1095; DOI: https://doi.org/10.2215/CJN.00510107
    2. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview
      Glenn M. Chertow, Lara B. Pupim, Geoffrey A. Block, Ricardo Correa-Rotter, Tilman B. Drueke, Jürgen Floege, William G. Goodman, Gerard M. London, Kenneth W. Mahaffey, Sharon M. Moe, David C. Wheeler, Moetaz Albizem, Kurt Olson, Preston Klassen and Patrick Parfrey
      CJASN September 2007, 2 (5) 898-905; DOI: https://doi.org/10.2215/CJN.04381206

  6. Chiodini, Paolo

    1. Stability of Target Hemoglobin Levels during the First Year of Epoetin Treatment in Patients with Chronic Kidney Disease
      Luca De Nicola, Giuseppe Conte, Paolo Chiodini, Bruno Cianciaruso, Andrea Pota, Vincenzo Bellizzi, Giuseppina Tirino, Deborah Avino, Fausta Catapano and Roberto Minutolo
      CJASN September 2007, 2 (5) 938-946; DOI: https://doi.org/10.2215/CJN.01690407

  7. Cho, Monique E.

    1. Pirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis
      Monique E. Cho, David C. Smith, Mary H. Branton, Scott R. Penzak and Jeffrey B. Kopp
      CJASN September 2007, 2 (5) 906-913; DOI: https://doi.org/10.2215/CJN.01050207

  8. Cianciaruso, Bruno

    1. Stability of Target Hemoglobin Levels during the First Year of Epoetin Treatment in Patients with Chronic Kidney Disease
      Luca De Nicola, Giuseppe Conte, Paolo Chiodini, Bruno Cianciaruso, Andrea Pota, Vincenzo Bellizzi, Giuseppina Tirino, Deborah Avino, Fausta Catapano and Roberto Minutolo
      CJASN September 2007, 2 (5) 938-946; DOI: https://doi.org/10.2215/CJN.01690407

  9. Cohen, Eric P.

    1. Subdural Hematomas in Chronic Dialysis Patients: Significant and Increasing
      Puneet Sood, Grant P. Sinson and Eric P. Cohen
      CJASN September 2007, 2 (5) 956-959; DOI: https://doi.org/10.2215/CJN.03781106

  10. Cohen, Scott D.

    1. Pain, Sleep Disturbance, and Quality of Life in Patients with Chronic Kidney Disease
      Scott D. Cohen, Samir S. Patel, Prashant Khetpal, Rolf A. Peterson and Paul L. Kimmel
      CJASN September 2007, 2 (5) 919-925; DOI: https://doi.org/10.2215/CJN.00820207

  11. Conte, Giuseppe

    1. Stability of Target Hemoglobin Levels during the First Year of Epoetin Treatment in Patients with Chronic Kidney Disease
      Luca De Nicola, Giuseppe Conte, Paolo Chiodini, Bruno Cianciaruso, Andrea Pota, Vincenzo Bellizzi, Giuseppina Tirino, Deborah Avino, Fausta Catapano and Roberto Minutolo
      CJASN September 2007, 2 (5) 938-946; DOI: https://doi.org/10.2215/CJN.01690407

  12. Contreras, Gabriel

    1. Role of Mycophenolate Mofetil in the Treatment of Lupus Nephritis
      Gabriel Contreras and Jonathan Sosnov
      CJASN September 2007, 2 (5) 879-882; DOI: https://doi.org/10.2215/CJN.02740707

  13. Cooksey, Stephen H.

    1. Renal Provider Recognition of Symptoms in Patients on Maintenance Hemodialysis
      Steven D. Weisbord, Linda F. Fried, Maria K. Mor, Abby L. Resnick, Mark L. Unruh, Paul M. Palevsky, David J. Levenson, Stephen H. Cooksey, Michael J. Fine, Paul L. Kimmel and Robert M. Arnold
      CJASN September 2007, 2 (5) 960-967; DOI: https://doi.org/10.2215/CJN.00990207

  14. Copelovitch, Lawrence

    1. Hypothesis: Dent Disease Is an Underrecognized Cause of Focal Glomerulosclerosis
      Lawrence Copelovitch, Martin A. Nash and Bernard S. Kaplan
      CJASN September 2007, 2 (5) 914-918; DOI: https://doi.org/10.2215/CJN.00900207

  15. Correa-Rotter, Ricardo

    1. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview
      Glenn M. Chertow, Lara B. Pupim, Geoffrey A. Block, Ricardo Correa-Rotter, Tilman B. Drueke, Jürgen Floege, William G. Goodman, Gerard M. London, Kenneth W. Mahaffey, Sharon M. Moe, David C. Wheeler, Moetaz Albizem, Kurt Olson, Preston Klassen and Patrick Parfrey
      CJASN September 2007, 2 (5) 898-905; DOI: https://doi.org/10.2215/CJN.04381206

  16. Cravedi, Paolo

    1. Titrating Rituximab to Circulating B Cells to Optimize Lymphocytolytic Therapy in Idiopathic Membranous Nephropathy
      Paolo Cravedi, Piero Ruggenenti, Maria Chiara Sghirlanzoni and Giuseppe Remuzzi
      CJASN September 2007, 2 (5) 932-937; DOI: https://doi.org/10.2215/CJN.01180307

D

  1. De Berardis, Giorgia

    1. Identifying Patients at Risk for Microalbuminuria via Interaction of the Components of the Metabolic Syndrome: A Cross-Sectional Analytic Study
      Monica Franciosi, Fabio Pellegrini, Michele Sacco, Giorgia De Berardis, Maria C.E. Rossi, Giovanni F.M. Strippoli, Maurizio Belfiglio, Gianni Tognoni, Miriam Valentini, Antonio Nicolucci and ; on behalf of the IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group
      CJASN September 2007, 2 (5) 984-991; DOI: https://doi.org/10.2215/CJN.01190307

  2. de Boccardo, Graciella

    1. Routine Use of Ambulatory Blood Pressure Monitoring in Potential Living Kidney Donors
      Elizabeth S. Ommen, Bernd Schröppel, Jin-Yon Kim, Gabrielle Gaspard, Enver Akalin, Graciella de Boccardo, Vinita Sehgal, Michael Lipkowitz and Barbara Murphy
      CJASN September 2007, 2 (5) 1030-1036; DOI: https://doi.org/10.2215/CJN.01240307

  3. De Nicola, Luca

    1. Stability of Target Hemoglobin Levels during the First Year of Epoetin Treatment in Patients with Chronic Kidney Disease
      Luca De Nicola, Giuseppe Conte, Paolo Chiodini, Bruno Cianciaruso, Andrea Pota, Vincenzo Bellizzi, Giuseppina Tirino, Deborah Avino, Fausta Catapano and Roberto Minutolo
      CJASN September 2007, 2 (5) 938-946; DOI: https://doi.org/10.2215/CJN.01690407

  4. Desai, Amar A.

    1. Rise of Pay for Performance: Implications for Care of People with Chronic Kidney Disease
      Amar A. Desai, Alan M. Garber and Glenn M. Chertow
      CJASN September 2007, 2 (5) 1087-1095; DOI: https://doi.org/10.2215/CJN.00510107

  5. Dharnidharka, Vikas R.

    1. BK Virus Nephropathy in Pediatric Renal Transplant Recipients: An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry
      Jodi M. Smith, Vikas R. Dharnidharka, Lynya Talley, Karen Martz and Ruth A. McDonald
      CJASN September 2007, 2 (5) 1037-1042; DOI: https://doi.org/10.2215/CJN.04051206

  6. Drueke, Tilman B.

    1. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview
      Glenn M. Chertow, Lara B. Pupim, Geoffrey A. Block, Ricardo Correa-Rotter, Tilman B. Drueke, Jürgen Floege, William G. Goodman, Gerard M. London, Kenneth W. Mahaffey, Sharon M. Moe, David C. Wheeler, Moetaz Albizem, Kurt Olson, Preston Klassen and Patrick Parfrey
      CJASN September 2007, 2 (5) 898-905; DOI: https://doi.org/10.2215/CJN.04381206

F

  1. Figurski, Michal

    1. Therapeutic Drug Monitoring of Mycophenolic Acid
      Leslie M. Shaw, Michal Figurski, Michael C. Milone, Jennifer Trofe and Roy D. Bloom
      CJASN September 2007, 2 (5) 1062-1072; DOI: https://doi.org/10.2215/CJN.03861106

  2. Fine, Michael J.

    1. Renal Provider Recognition of Symptoms in Patients on Maintenance Hemodialysis
      Steven D. Weisbord, Linda F. Fried, Maria K. Mor, Abby L. Resnick, Mark L. Unruh, Paul M. Palevsky, David J. Levenson, Stephen H. Cooksey, Michael J. Fine, Paul L. Kimmel and Robert M. Arnold
      CJASN September 2007, 2 (5) 960-967; DOI: https://doi.org/10.2215/CJN.00990207

  3. Fisher, Naomi D.L.

    1. Gender and the Renal Nitric Oxide Synthase System in Healthy Humans
      Sofia B. Ahmed, Naomi D.L. Fisher and Norman K. Hollenberg
      CJASN September 2007, 2 (5) 926-931; DOI: https://doi.org/10.2215/CJN.00110107

  4. Floege, Jürgen

    1. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview
      Glenn M. Chertow, Lara B. Pupim, Geoffrey A. Block, Ricardo Correa-Rotter, Tilman B. Drueke, Jürgen Floege, William G. Goodman, Gerard M. London, Kenneth W. Mahaffey, Sharon M. Moe, David C. Wheeler, Moetaz Albizem, Kurt Olson, Preston Klassen and Patrick Parfrey
      CJASN September 2007, 2 (5) 898-905; DOI: https://doi.org/10.2215/CJN.04381206

  5. Flowers, Mary E.D.

    1. Spectrum of Renal Pathology in Hematopoietic Cell Transplantation: A Series of 20 Patients and Review of the Literature
      Anthony Chang, Sangeeta Hingorani, Jolanta Kowalewska, Mary E.D. Flowers, Tia Aneja, Kelly D. Smith, Shane M. Meehan, Roberto F. Nicosia and Charles E. Alpers
      CJASN September 2007, 2 (5) 1014-1023; DOI: https://doi.org/10.2215/CJN.01700407

  6. Franciosi, Monica

    1. Identifying Patients at Risk for Microalbuminuria via Interaction of the Components of the Metabolic Syndrome: A Cross-Sectional Analytic Study
      Monica Franciosi, Fabio Pellegrini, Michele Sacco, Giorgia De Berardis, Maria C.E. Rossi, Giovanni F.M. Strippoli, Maurizio Belfiglio, Gianni Tognoni, Miriam Valentini, Antonio Nicolucci and ; on behalf of the IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group
      CJASN September 2007, 2 (5) 984-991; DOI: https://doi.org/10.2215/CJN.01190307

  7. Fried, Linda F.

    1. Renal Provider Recognition of Symptoms in Patients on Maintenance Hemodialysis
      Steven D. Weisbord, Linda F. Fried, Maria K. Mor, Abby L. Resnick, Mark L. Unruh, Paul M. Palevsky, David J. Levenson, Stephen H. Cooksey, Michael J. Fine, Paul L. Kimmel and Robert M. Arnold
      CJASN September 2007, 2 (5) 960-967; DOI: https://doi.org/10.2215/CJN.00990207

G

  1. Garber, Alan M.

    1. Rise of Pay for Performance: Implications for Care of People with Chronic Kidney Disease
      Amar A. Desai, Alan M. Garber and Glenn M. Chertow
      CJASN September 2007, 2 (5) 1087-1095; DOI: https://doi.org/10.2215/CJN.00510107

  2. Gaspard, Gabrielle

    1. Routine Use of Ambulatory Blood Pressure Monitoring in Potential Living Kidney Donors
      Elizabeth S. Ommen, Bernd Schröppel, Jin-Yon Kim, Gabrielle Gaspard, Enver Akalin, Graciella de Boccardo, Vinita Sehgal, Michael Lipkowitz and Barbara Murphy
      CJASN September 2007, 2 (5) 1030-1036; DOI: https://doi.org/10.2215/CJN.01240307

  3. Ghanbarian, Arash

    1. Are Patients Who Have Metabolic Syndrome without Diabetes at Risk for Developing Chronic Kidney Disease? Evidence Based on Data from a Large Cohort Screening Population
      Arash Rashidi, Arash Ghanbarian and Fereidoun Azizi
      CJASN September 2007, 2 (5) 976-983; DOI: https://doi.org/10.2215/CJN.01020207

  4. Goodman, William G.

    1. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview
      Glenn M. Chertow, Lara B. Pupim, Geoffrey A. Block, Ricardo Correa-Rotter, Tilman B. Drueke, Jürgen Floege, William G. Goodman, Gerard M. London, Kenneth W. Mahaffey, Sharon M. Moe, David C. Wheeler, Moetaz Albizem, Kurt Olson, Preston Klassen and Patrick Parfrey
      CJASN September 2007, 2 (5) 898-905; DOI: https://doi.org/10.2215/CJN.04381206

  5. Greenland, Sander

    1. Serum and Dialysate Potassium Concentrations and Survival in Hemodialysis Patients
      Csaba P. Kovesdy, Deborah L. Regidor, Rajnish Mehrotra, Jennie Jing, Charles J. McAllister, Sander Greenland, Joel D. Kopple and Kamyar Kalantar-Zadeh
      CJASN September 2007, 2 (5) 999-1007; DOI: https://doi.org/10.2215/CJN.04451206

  6. Guyene, Than-Tam

    1. Hormonal and Hemodynamic Effects of Aliskiren and Valsartan and Their Combination in Sodium-Replete Normotensive Individuals
      Michel Azizi, Joël Ménard, Alvine Bissery, Than-Tam Guyene and Alessandra Bura-Rivière
      CJASN September 2007, 2 (5) 947-955; DOI: https://doi.org/10.2215/CJN.00360107

H

  1. Heimbürger, Olof

    1. Plasma Pentraxin 3 in Patients with Chronic Kidney Disease: Associations with Renal Function, Protein-Energy Wasting, Cardiovascular Disease, and Mortality
      Mengli Tong, Juan Jesús Carrero, A. Rashid Qureshi, Björn Anderstam, Olof Heimbürger, Peter Bárány, Jonas Axelsson, Anders Alvestrand, Peter Stenvinkel, Bengt Lindholm and Mohamed E. Suliman
      CJASN September 2007, 2 (5) 889-897; DOI: https://doi.org/10.2215/CJN.00870207

  2. Hemmelgarn, Brenda R.

    1. Mycophenolate Mofetil for Induction Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis
      Michael Walsh, Matthew James, David Jayne, Marcello Tonelli, Braden J. Manns and Brenda R. Hemmelgarn
      CJASN September 2007, 2 (5) 968-975; DOI: https://doi.org/10.2215/CJN.01200307

  3. Hennigar, Randolph

    1. Idiopathic IgA Nephropathy: Pathogenesis, Histopathology, and Therapeutic Options
      James A. Tumlin, Michael P. Madaio and Randolph Hennigar
      CJASN September 2007, 2 (5) 1054-1061; DOI: https://doi.org/10.2215/CJN.04351206

  4. Hingorani, Sangeeta

    1. Spectrum of Renal Pathology in Hematopoietic Cell Transplantation: A Series of 20 Patients and Review of the Literature
      Anthony Chang, Sangeeta Hingorani, Jolanta Kowalewska, Mary E.D. Flowers, Tia Aneja, Kelly D. Smith, Shane M. Meehan, Roberto F. Nicosia and Charles E. Alpers
      CJASN September 2007, 2 (5) 1014-1023; DOI: https://doi.org/10.2215/CJN.01700407

  5. Hollenberg, Norman K.

    1. Gender and the Renal Nitric Oxide Synthase System in Healthy Humans
      Sofia B. Ahmed, Naomi D.L. Fisher and Norman K. Hollenberg
      CJASN September 2007, 2 (5) 926-931; DOI: https://doi.org/10.2215/CJN.00110107

J

  1. Jaber, Bertrand L.

    1. Single-Use versus Reusable Dialyzers: The Known Unknowns
      Ashish Upadhyay, Marie Anne Sosa and Bertrand L. Jaber
      CJASN September 2007, 2 (5) 1079-1086; DOI: https://doi.org/10.2215/CJN.01040207

  2. James, Matthew

    1. Mycophenolate Mofetil for Induction Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis
      Michael Walsh, Matthew James, David Jayne, Marcello Tonelli, Braden J. Manns and Brenda R. Hemmelgarn
      CJASN September 2007, 2 (5) 968-975; DOI: https://doi.org/10.2215/CJN.01200307

  3. Jayne, David

    1. Mycophenolate Mofetil for Induction Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis
      Michael Walsh, Matthew James, David Jayne, Marcello Tonelli, Braden J. Manns and Brenda R. Hemmelgarn
      CJASN September 2007, 2 (5) 968-975; DOI: https://doi.org/10.2215/CJN.01200307

  4. Jing, Jennie

    1. Serum and Dialysate Potassium Concentrations and Survival in Hemodialysis Patients
      Csaba P. Kovesdy, Deborah L. Regidor, Rajnish Mehrotra, Jennie Jing, Charles J. McAllister, Sander Greenland, Joel D. Kopple and Kamyar Kalantar-Zadeh
      CJASN September 2007, 2 (5) 999-1007; DOI: https://doi.org/10.2215/CJN.04451206

K

  1. Kalantar-Zadeh, Kamyar

    1. Inflammatory Marker Mania in Chronic Kidney Disease: Pentraxins at the Crossroad of Universal Soldiers of Inflammation
      Kamyar Kalantar-Zadeh
      CJASN September 2007, 2 (5) 872-875; DOI: https://doi.org/10.2215/CJN.02750707
    2. Serum and Dialysate Potassium Concentrations and Survival in Hemodialysis Patients
      Csaba P. Kovesdy, Deborah L. Regidor, Rajnish Mehrotra, Jennie Jing, Charles J. McAllister, Sander Greenland, Joel D. Kopple and Kamyar Kalantar-Zadeh
      CJASN September 2007, 2 (5) 999-1007; DOI: https://doi.org/10.2215/CJN.04451206
    3. Obesity Is Associated with Secondary Hyperparathyroidism in Men with Moderate and Severe Chronic Kidney Disease
      Csaba P. Kovesdy, Shahram Ahmadzadeh, John E. Anderson and Kamyar Kalantar-Zadeh
      CJASN September 2007, 2 (5) 1024-1029; DOI: https://doi.org/10.2215/CJN.01970507

  2. Kaplan, Bernard S.

    1. Hypothesis: Dent Disease Is an Underrecognized Cause of Focal Glomerulosclerosis
      Lawrence Copelovitch, Martin A. Nash and Bernard S. Kaplan
      CJASN September 2007, 2 (5) 914-918; DOI: https://doi.org/10.2215/CJN.00900207

  3. Kayani, Zainab Z.

    1. Comparison of Stage at Diagnosis of Cancer in Patients Who Are on Dialysis versus the General Population
      Shilpa Taneja, Sreedhar Mandayam, Zainab Z. Kayani, Yong-Fang Kuo and Vahakn B. Shahinian
      CJASN September 2007, 2 (5) 1008-1013; DOI: https://doi.org/10.2215/CJN.00310107

  4. Khetpal, Prashant

    1. Pain, Sleep Disturbance, and Quality of Life in Patients with Chronic Kidney Disease
      Scott D. Cohen, Samir S. Patel, Prashant Khetpal, Rolf A. Peterson and Paul L. Kimmel
      CJASN September 2007, 2 (5) 919-925; DOI: https://doi.org/10.2215/CJN.00820207

  5. Kim, Jin-Yon

    1. Routine Use of Ambulatory Blood Pressure Monitoring in Potential Living Kidney Donors
      Elizabeth S. Ommen, Bernd Schröppel, Jin-Yon Kim, Gabrielle Gaspard, Enver Akalin, Graciella de Boccardo, Vinita Sehgal, Michael Lipkowitz and Barbara Murphy
      CJASN September 2007, 2 (5) 1030-1036; DOI: https://doi.org/10.2215/CJN.01240307

  6. Kimmel, Paul L.

    1. Pain, Sleep Disturbance, and Quality of Life in Patients with Chronic Kidney Disease
      Scott D. Cohen, Samir S. Patel, Prashant Khetpal, Rolf A. Peterson and Paul L. Kimmel
      CJASN September 2007, 2 (5) 919-925; DOI: https://doi.org/10.2215/CJN.00820207
    2. Renal Provider Recognition of Symptoms in Patients on Maintenance Hemodialysis
      Steven D. Weisbord, Linda F. Fried, Maria K. Mor, Abby L. Resnick, Mark L. Unruh, Paul M. Palevsky, David J. Levenson, Stephen H. Cooksey, Michael J. Fine, Paul L. Kimmel and Robert M. Arnold
      CJASN September 2007, 2 (5) 960-967; DOI: https://doi.org/10.2215/CJN.00990207

  7. Klassen, Preston

    1. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview
      Glenn M. Chertow, Lara B. Pupim, Geoffrey A. Block, Ricardo Correa-Rotter, Tilman B. Drueke, Jürgen Floege, William G. Goodman, Gerard M. London, Kenneth W. Mahaffey, Sharon M. Moe, David C. Wheeler, Moetaz Albizem, Kurt Olson, Preston Klassen and Patrick Parfrey
      CJASN September 2007, 2 (5) 898-905; DOI: https://doi.org/10.2215/CJN.04381206

  8. Kopp, Jeffrey B.

    1. Pirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis
      Monique E. Cho, David C. Smith, Mary H. Branton, Scott R. Penzak and Jeffrey B. Kopp
      CJASN September 2007, 2 (5) 906-913; DOI: https://doi.org/10.2215/CJN.01050207

  9. Kopple, Joel D.

    1. Serum and Dialysate Potassium Concentrations and Survival in Hemodialysis Patients
      Csaba P. Kovesdy, Deborah L. Regidor, Rajnish Mehrotra, Jennie Jing, Charles J. McAllister, Sander Greenland, Joel D. Kopple and Kamyar Kalantar-Zadeh
      CJASN September 2007, 2 (5) 999-1007; DOI: https://doi.org/10.2215/CJN.04451206

  10. Kovesdy, Csaba P.

    1. Serum and Dialysate Potassium Concentrations and Survival in Hemodialysis Patients
      Csaba P. Kovesdy, Deborah L. Regidor, Rajnish Mehrotra, Jennie Jing, Charles J. McAllister, Sander Greenland, Joel D. Kopple and Kamyar Kalantar-Zadeh
      CJASN September 2007, 2 (5) 999-1007; DOI: https://doi.org/10.2215/CJN.04451206
    2. Obesity Is Associated with Secondary Hyperparathyroidism in Men with Moderate and Severe Chronic Kidney Disease
      Csaba P. Kovesdy, Shahram Ahmadzadeh, John E. Anderson and Kamyar Kalantar-Zadeh
      CJASN September 2007, 2 (5) 1024-1029; DOI: https://doi.org/10.2215/CJN.01970507

  11. Kowalewska, Jolanta

    1. Spectrum of Renal Pathology in Hematopoietic Cell Transplantation: A Series of 20 Patients and Review of the Literature
      Anthony Chang, Sangeeta Hingorani, Jolanta Kowalewska, Mary E.D. Flowers, Tia Aneja, Kelly D. Smith, Shane M. Meehan, Roberto F. Nicosia and Charles E. Alpers
      CJASN September 2007, 2 (5) 1014-1023; DOI: https://doi.org/10.2215/CJN.01700407

  12. Kuo, Yong-Fang

    1. Comparison of Stage at Diagnosis of Cancer in Patients Who Are on Dialysis versus the General Population
      Shilpa Taneja, Sreedhar Mandayam, Zainab Z. Kayani, Yong-Fang Kuo and Vahakn B. Shahinian
      CJASN September 2007, 2 (5) 1008-1013; DOI: https://doi.org/10.2215/CJN.00310107

  13. Kwan, Bonnie C.H.

    1. Associations of Body Size with Metabolic Syndrome and Mortality in Moderate Chronic Kidney Disease
      Bonnie C.H. Kwan, Maureen A. Murtaugh and Srinivasan Beddhu
      CJASN September 2007, 2 (5) 992-998; DOI: https://doi.org/10.2215/CJN.04221206

L

  1. Levenson, David J.

    1. Renal Provider Recognition of Symptoms in Patients on Maintenance Hemodialysis
      Steven D. Weisbord, Linda F. Fried, Maria K. Mor, Abby L. Resnick, Mark L. Unruh, Paul M. Palevsky, David J. Levenson, Stephen H. Cooksey, Michael J. Fine, Paul L. Kimmel and Robert M. Arnold
      CJASN September 2007, 2 (5) 960-967; DOI: https://doi.org/10.2215/CJN.00990207

  2. Lindholm, Bengt

    1. Plasma Pentraxin 3 in Patients with Chronic Kidney Disease: Associations with Renal Function, Protein-Energy Wasting, Cardiovascular Disease, and Mortality
      Mengli Tong, Juan Jesús Carrero, A. Rashid Qureshi, Björn Anderstam, Olof Heimbürger, Peter Bárány, Jonas Axelsson, Anders Alvestrand, Peter Stenvinkel, Bengt Lindholm and Mohamed E. Suliman
      CJASN September 2007, 2 (5) 889-897; DOI: https://doi.org/10.2215/CJN.00870207

  3. Lipkowitz, Michael

    1. Routine Use of Ambulatory Blood Pressure Monitoring in Potential Living Kidney Donors
      Elizabeth S. Ommen, Bernd Schröppel, Jin-Yon Kim, Gabrielle Gaspard, Enver Akalin, Graciella de Boccardo, Vinita Sehgal, Michael Lipkowitz and Barbara Murphy
      CJASN September 2007, 2 (5) 1030-1036; DOI: https://doi.org/10.2215/CJN.01240307

  4. Lok, Charmaine E.

    1. Fistula First Initiative: Advantages and Pitfalls
      Charmaine E. Lok
      CJASN September 2007, 2 (5) 1043-1053; DOI: https://doi.org/10.2215/CJN.01080307

  5. London, Gerard M.

    1. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview
      Glenn M. Chertow, Lara B. Pupim, Geoffrey A. Block, Ricardo Correa-Rotter, Tilman B. Drueke, Jürgen Floege, William G. Goodman, Gerard M. London, Kenneth W. Mahaffey, Sharon M. Moe, David C. Wheeler, Moetaz Albizem, Kurt Olson, Preston Klassen and Patrick Parfrey
      CJASN September 2007, 2 (5) 898-905; DOI: https://doi.org/10.2215/CJN.04381206

M

  1. Maalouf, Naim M.

    1. Low Urine pH: A Novel Feature of the Metabolic Syndrome
      Naim M. Maalouf, Mary Ann Cameron, Orson W. Moe, Beverley Adams-Huet and Khashayar Sakhaee
      CJASN September 2007, 2 (5) 883-888; DOI: https://doi.org/10.2215/CJN.00670207

  2. Madaio, Michael P.

    1. Idiopathic IgA Nephropathy: Pathogenesis, Histopathology, and Therapeutic Options
      James A. Tumlin, Michael P. Madaio and Randolph Hennigar
      CJASN September 2007, 2 (5) 1054-1061; DOI: https://doi.org/10.2215/CJN.04351206

  3. Mahaffey, Kenneth W.

    1. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview
      Glenn M. Chertow, Lara B. Pupim, Geoffrey A. Block, Ricardo Correa-Rotter, Tilman B. Drueke, Jürgen Floege, William G. Goodman, Gerard M. London, Kenneth W. Mahaffey, Sharon M. Moe, David C. Wheeler, Moetaz Albizem, Kurt Olson, Preston Klassen and Patrick Parfrey
      CJASN September 2007, 2 (5) 898-905; DOI: https://doi.org/10.2215/CJN.04381206

  4. Mandayam, Sreedhar

    1. Comparison of Stage at Diagnosis of Cancer in Patients Who Are on Dialysis versus the General Population
      Shilpa Taneja, Sreedhar Mandayam, Zainab Z. Kayani, Yong-Fang Kuo and Vahakn B. Shahinian
      CJASN September 2007, 2 (5) 1008-1013; DOI: https://doi.org/10.2215/CJN.00310107

  5. Manns, Braden J.

    1. Mycophenolate Mofetil for Induction Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis
      Michael Walsh, Matthew James, David Jayne, Marcello Tonelli, Braden J. Manns and Brenda R. Hemmelgarn
      CJASN September 2007, 2 (5) 968-975; DOI: https://doi.org/10.2215/CJN.01200307

  6. Martz, Karen

    1. BK Virus Nephropathy in Pediatric Renal Transplant Recipients: An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry
      Jodi M. Smith, Vikas R. Dharnidharka, Lynya Talley, Karen Martz and Ruth A. McDonald
      CJASN September 2007, 2 (5) 1037-1042; DOI: https://doi.org/10.2215/CJN.04051206

  7. McAllister, Charles J.

    1. Serum and Dialysate Potassium Concentrations and Survival in Hemodialysis Patients
      Csaba P. Kovesdy, Deborah L. Regidor, Rajnish Mehrotra, Jennie Jing, Charles J. McAllister, Sander Greenland, Joel D. Kopple and Kamyar Kalantar-Zadeh
      CJASN September 2007, 2 (5) 999-1007; DOI: https://doi.org/10.2215/CJN.04451206

  8. McDonald, Ruth A.

    1. BK Virus Nephropathy in Pediatric Renal Transplant Recipients: An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry
      Jodi M. Smith, Vikas R. Dharnidharka, Lynya Talley, Karen Martz and Ruth A. McDonald
      CJASN September 2007, 2 (5) 1037-1042; DOI: https://doi.org/10.2215/CJN.04051206

  9. Meehan, Shane M.

    1. Spectrum of Renal Pathology in Hematopoietic Cell Transplantation: A Series of 20 Patients and Review of the Literature
      Anthony Chang, Sangeeta Hingorani, Jolanta Kowalewska, Mary E.D. Flowers, Tia Aneja, Kelly D. Smith, Shane M. Meehan, Roberto F. Nicosia and Charles E. Alpers
      CJASN September 2007, 2 (5) 1014-1023; DOI: https://doi.org/10.2215/CJN.01700407

  10. Mehrotra, Rajnish

    1. Serum and Dialysate Potassium Concentrations and Survival in Hemodialysis Patients
      Csaba P. Kovesdy, Deborah L. Regidor, Rajnish Mehrotra, Jennie Jing, Charles J. McAllister, Sander Greenland, Joel D. Kopple and Kamyar Kalantar-Zadeh
      CJASN September 2007, 2 (5) 999-1007; DOI: https://doi.org/10.2215/CJN.04451206

  11. Ménard, Joël

    1. Hormonal and Hemodynamic Effects of Aliskiren and Valsartan and Their Combination in Sodium-Replete Normotensive Individuals
      Michel Azizi, Joël Ménard, Alvine Bissery, Than-Tam Guyene and Alessandra Bura-Rivière
      CJASN September 2007, 2 (5) 947-955; DOI: https://doi.org/10.2215/CJN.00360107

  12. Milone, Michael C.

    1. Therapeutic Drug Monitoring of Mycophenolic Acid
      Leslie M. Shaw, Michal Figurski, Michael C. Milone, Jennifer Trofe and Roy D. Bloom
      CJASN September 2007, 2 (5) 1062-1072; DOI: https://doi.org/10.2215/CJN.03861106

  13. Minutolo, Roberto

    1. Stability of Target Hemoglobin Levels during the First Year of Epoetin Treatment in Patients with Chronic Kidney Disease
      Luca De Nicola, Giuseppe Conte, Paolo Chiodini, Bruno Cianciaruso, Andrea Pota, Vincenzo Bellizzi, Giuseppina Tirino, Deborah Avino, Fausta Catapano and Roberto Minutolo
      CJASN September 2007, 2 (5) 938-946; DOI: https://doi.org/10.2215/CJN.01690407

  14. Moe, Orson W.

    1. Low Urine pH: A Novel Feature of the Metabolic Syndrome
      Naim M. Maalouf, Mary Ann Cameron, Orson W. Moe, Beverley Adams-Huet and Khashayar Sakhaee
      CJASN September 2007, 2 (5) 883-888; DOI: https://doi.org/10.2215/CJN.00670207

  15. Moe, Sharon M.

    1. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview
      Glenn M. Chertow, Lara B. Pupim, Geoffrey A. Block, Ricardo Correa-Rotter, Tilman B. Drueke, Jürgen Floege, William G. Goodman, Gerard M. London, Kenneth W. Mahaffey, Sharon M. Moe, David C. Wheeler, Moetaz Albizem, Kurt Olson, Preston Klassen and Patrick Parfrey
      CJASN September 2007, 2 (5) 898-905; DOI: https://doi.org/10.2215/CJN.04381206

  16. Mor, Maria K.

    1. Renal Provider Recognition of Symptoms in Patients on Maintenance Hemodialysis
      Steven D. Weisbord, Linda F. Fried, Maria K. Mor, Abby L. Resnick, Mark L. Unruh, Paul M. Palevsky, David J. Levenson, Stephen H. Cooksey, Michael J. Fine, Paul L. Kimmel and Robert M. Arnold
      CJASN September 2007, 2 (5) 960-967; DOI: https://doi.org/10.2215/CJN.00990207

  17. Murphy, Barbara

    1. Routine Use of Ambulatory Blood Pressure Monitoring in Potential Living Kidney Donors
      Elizabeth S. Ommen, Bernd Schröppel, Jin-Yon Kim, Gabrielle Gaspard, Enver Akalin, Graciella de Boccardo, Vinita Sehgal, Michael Lipkowitz and Barbara Murphy
      CJASN September 2007, 2 (5) 1030-1036; DOI: https://doi.org/10.2215/CJN.01240307

  18. Murtaugh, Maureen A.

    1. Associations of Body Size with Metabolic Syndrome and Mortality in Moderate Chronic Kidney Disease
      Bonnie C.H. Kwan, Maureen A. Murtaugh and Srinivasan Beddhu
      CJASN September 2007, 2 (5) 992-998; DOI: https://doi.org/10.2215/CJN.04221206

N

  1. Nash, Martin A.

    1. Hypothesis: Dent Disease Is an Underrecognized Cause of Focal Glomerulosclerosis
      Lawrence Copelovitch, Martin A. Nash and Bernard S. Kaplan
      CJASN September 2007, 2 (5) 914-918; DOI: https://doi.org/10.2215/CJN.00900207

  2. Nicolucci, Antonio

    1. Identifying Patients at Risk for Microalbuminuria via Interaction of the Components of the Metabolic Syndrome: A Cross-Sectional Analytic Study
      Monica Franciosi, Fabio Pellegrini, Michele Sacco, Giorgia De Berardis, Maria C.E. Rossi, Giovanni F.M. Strippoli, Maurizio Belfiglio, Gianni Tognoni, Miriam Valentini, Antonio Nicolucci and ; on behalf of the IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group
      CJASN September 2007, 2 (5) 984-991; DOI: https://doi.org/10.2215/CJN.01190307

  3. Nicosia, Roberto F.

    1. Spectrum of Renal Pathology in Hematopoietic Cell Transplantation: A Series of 20 Patients and Review of the Literature
      Anthony Chang, Sangeeta Hingorani, Jolanta Kowalewska, Mary E.D. Flowers, Tia Aneja, Kelly D. Smith, Shane M. Meehan, Roberto F. Nicosia and Charles E. Alpers
      CJASN September 2007, 2 (5) 1014-1023; DOI: https://doi.org/10.2215/CJN.01700407

O

  1. Olson, Kurt

    1. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview
      Glenn M. Chertow, Lara B. Pupim, Geoffrey A. Block, Ricardo Correa-Rotter, Tilman B. Drueke, Jürgen Floege, William G. Goodman, Gerard M. London, Kenneth W. Mahaffey, Sharon M. Moe, David C. Wheeler, Moetaz Albizem, Kurt Olson, Preston Klassen and Patrick Parfrey
      CJASN September 2007, 2 (5) 898-905; DOI: https://doi.org/10.2215/CJN.04381206

  2. Ommen, Elizabeth S.

    1. Routine Use of Ambulatory Blood Pressure Monitoring in Potential Living Kidney Donors
      Elizabeth S. Ommen, Bernd Schröppel, Jin-Yon Kim, Gabrielle Gaspard, Enver Akalin, Graciella de Boccardo, Vinita Sehgal, Michael Lipkowitz and Barbara Murphy
      CJASN September 2007, 2 (5) 1030-1036; DOI: https://doi.org/10.2215/CJN.01240307

P

  1. Palevsky, Paul M.

    1. Renal Provider Recognition of Symptoms in Patients on Maintenance Hemodialysis
      Steven D. Weisbord, Linda F. Fried, Maria K. Mor, Abby L. Resnick, Mark L. Unruh, Paul M. Palevsky, David J. Levenson, Stephen H. Cooksey, Michael J. Fine, Paul L. Kimmel and Robert M. Arnold
      CJASN September 2007, 2 (5) 960-967; DOI: https://doi.org/10.2215/CJN.00990207

  2. Parfrey, Patrick

    1. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview
      Glenn M. Chertow, Lara B. Pupim, Geoffrey A. Block, Ricardo Correa-Rotter, Tilman B. Drueke, Jürgen Floege, William G. Goodman, Gerard M. London, Kenneth W. Mahaffey, Sharon M. Moe, David C. Wheeler, Moetaz Albizem, Kurt Olson, Preston Klassen and Patrick Parfrey
      CJASN September 2007, 2 (5) 898-905; DOI: https://doi.org/10.2215/CJN.04381206

  3. Patel, Samir S.

    1. Pain, Sleep Disturbance, and Quality of Life in Patients with Chronic Kidney Disease
      Scott D. Cohen, Samir S. Patel, Prashant Khetpal, Rolf A. Peterson and Paul L. Kimmel
      CJASN September 2007, 2 (5) 919-925; DOI: https://doi.org/10.2215/CJN.00820207

  4. Pellegrini, Fabio

    1. Identifying Patients at Risk for Microalbuminuria via Interaction of the Components of the Metabolic Syndrome: A Cross-Sectional Analytic Study
      Monica Franciosi, Fabio Pellegrini, Michele Sacco, Giorgia De Berardis, Maria C.E. Rossi, Giovanni F.M. Strippoli, Maurizio Belfiglio, Gianni Tognoni, Miriam Valentini, Antonio Nicolucci and ; on behalf of the IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group
      CJASN September 2007, 2 (5) 984-991; DOI: https://doi.org/10.2215/CJN.01190307

  5. Penzak, Scott R.

    1. Pirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis
      Monique E. Cho, David C. Smith, Mary H. Branton, Scott R. Penzak and Jeffrey B. Kopp
      CJASN September 2007, 2 (5) 906-913; DOI: https://doi.org/10.2215/CJN.01050207

  6. Peterson, Rolf A.

    1. Pain, Sleep Disturbance, and Quality of Life in Patients with Chronic Kidney Disease
      Scott D. Cohen, Samir S. Patel, Prashant Khetpal, Rolf A. Peterson and Paul L. Kimmel
      CJASN September 2007, 2 (5) 919-925; DOI: https://doi.org/10.2215/CJN.00820207

  7. Pota, Andrea

    1. Stability of Target Hemoglobin Levels during the First Year of Epoetin Treatment in Patients with Chronic Kidney Disease
      Luca De Nicola, Giuseppe Conte, Paolo Chiodini, Bruno Cianciaruso, Andrea Pota, Vincenzo Bellizzi, Giuseppina Tirino, Deborah Avino, Fausta Catapano and Roberto Minutolo
      CJASN September 2007, 2 (5) 938-946; DOI: https://doi.org/10.2215/CJN.01690407

  8. Pupim, Lara B.

    1. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview
      Glenn M. Chertow, Lara B. Pupim, Geoffrey A. Block, Ricardo Correa-Rotter, Tilman B. Drueke, Jürgen Floege, William G. Goodman, Gerard M. London, Kenneth W. Mahaffey, Sharon M. Moe, David C. Wheeler, Moetaz Albizem, Kurt Olson, Preston Klassen and Patrick Parfrey
      CJASN September 2007, 2 (5) 898-905; DOI: https://doi.org/10.2215/CJN.04381206

Q

  1. Qureshi, A. Rashid

    1. Plasma Pentraxin 3 in Patients with Chronic Kidney Disease: Associations with Renal Function, Protein-Energy Wasting, Cardiovascular Disease, and Mortality
      Mengli Tong, Juan Jesús Carrero, A. Rashid Qureshi, Björn Anderstam, Olof Heimbürger, Peter Bárány, Jonas Axelsson, Anders Alvestrand, Peter Stenvinkel, Bengt Lindholm and Mohamed E. Suliman
      CJASN September 2007, 2 (5) 889-897; DOI: https://doi.org/10.2215/CJN.00870207

R

  1. Rashidi, Arash

    1. Are Patients Who Have Metabolic Syndrome without Diabetes at Risk for Developing Chronic Kidney Disease? Evidence Based on Data from a Large Cohort Screening Population
      Arash Rashidi, Arash Ghanbarian and Fereidoun Azizi
      CJASN September 2007, 2 (5) 976-983; DOI: https://doi.org/10.2215/CJN.01020207

  2. Regidor, Deborah L.

    1. Serum and Dialysate Potassium Concentrations and Survival in Hemodialysis Patients
      Csaba P. Kovesdy, Deborah L. Regidor, Rajnish Mehrotra, Jennie Jing, Charles J. McAllister, Sander Greenland, Joel D. Kopple and Kamyar Kalantar-Zadeh
      CJASN September 2007, 2 (5) 999-1007; DOI: https://doi.org/10.2215/CJN.04451206

  3. Remuzzi, Giuseppe

    1. Titrating Rituximab to Circulating B Cells to Optimize Lymphocytolytic Therapy in Idiopathic Membranous Nephropathy
      Paolo Cravedi, Piero Ruggenenti, Maria Chiara Sghirlanzoni and Giuseppe Remuzzi
      CJASN September 2007, 2 (5) 932-937; DOI: https://doi.org/10.2215/CJN.01180307

  4. Resnick, Abby L.

    1. Renal Provider Recognition of Symptoms in Patients on Maintenance Hemodialysis
      Steven D. Weisbord, Linda F. Fried, Maria K. Mor, Abby L. Resnick, Mark L. Unruh, Paul M. Palevsky, David J. Levenson, Stephen H. Cooksey, Michael J. Fine, Paul L. Kimmel and Robert M. Arnold
      CJASN September 2007, 2 (5) 960-967; DOI: https://doi.org/10.2215/CJN.00990207

  5. Ritz, Eberhard

    1. Metabolic Syndrome: An Emerging Threat to Renal Function
      Eberhard Ritz
      CJASN September 2007, 2 (5) 869-871; DOI: https://doi.org/10.2215/CJN.02350607

  6. Rossi, Maria C.E.

    1. Identifying Patients at Risk for Microalbuminuria via Interaction of the Components of the Metabolic Syndrome: A Cross-Sectional Analytic Study
      Monica Franciosi, Fabio Pellegrini, Michele Sacco, Giorgia De Berardis, Maria C.E. Rossi, Giovanni F.M. Strippoli, Maurizio Belfiglio, Gianni Tognoni, Miriam Valentini, Antonio Nicolucci and ; on behalf of the IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group
      CJASN September 2007, 2 (5) 984-991; DOI: https://doi.org/10.2215/CJN.01190307

  7. Ruggenenti, Piero

    1. Titrating Rituximab to Circulating B Cells to Optimize Lymphocytolytic Therapy in Idiopathic Membranous Nephropathy
      Paolo Cravedi, Piero Ruggenenti, Maria Chiara Sghirlanzoni and Giuseppe Remuzzi
      CJASN September 2007, 2 (5) 932-937; DOI: https://doi.org/10.2215/CJN.01180307

S

  1. Sacco, Michele

    1. Identifying Patients at Risk for Microalbuminuria via Interaction of the Components of the Metabolic Syndrome: A Cross-Sectional Analytic Study
      Monica Franciosi, Fabio Pellegrini, Michele Sacco, Giorgia De Berardis, Maria C.E. Rossi, Giovanni F.M. Strippoli, Maurizio Belfiglio, Gianni Tognoni, Miriam Valentini, Antonio Nicolucci and ; on behalf of the IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group
      CJASN September 2007, 2 (5) 984-991; DOI: https://doi.org/10.2215/CJN.01190307

  2. Sakhaee, Khashayar

    1. Low Urine pH: A Novel Feature of the Metabolic Syndrome
      Naim M. Maalouf, Mary Ann Cameron, Orson W. Moe, Beverley Adams-Huet and Khashayar Sakhaee
      CJASN September 2007, 2 (5) 883-888; DOI: https://doi.org/10.2215/CJN.00670207

  3. Schröppel, Bernd

    1. Routine Use of Ambulatory Blood Pressure Monitoring in Potential Living Kidney Donors
      Elizabeth S. Ommen, Bernd Schröppel, Jin-Yon Kim, Gabrielle Gaspard, Enver Akalin, Graciella de Boccardo, Vinita Sehgal, Michael Lipkowitz and Barbara Murphy
      CJASN September 2007, 2 (5) 1030-1036; DOI: https://doi.org/10.2215/CJN.01240307

  4. Sehgal, Vinita

    1. Routine Use of Ambulatory Blood Pressure Monitoring in Potential Living Kidney Donors
      Elizabeth S. Ommen, Bernd Schröppel, Jin-Yon Kim, Gabrielle Gaspard, Enver Akalin, Graciella de Boccardo, Vinita Sehgal, Michael Lipkowitz and Barbara Murphy
      CJASN September 2007, 2 (5) 1030-1036; DOI: https://doi.org/10.2215/CJN.01240307

  5. Sghirlanzoni, Maria Chiara

    1. Titrating Rituximab to Circulating B Cells to Optimize Lymphocytolytic Therapy in Idiopathic Membranous Nephropathy
      Paolo Cravedi, Piero Ruggenenti, Maria Chiara Sghirlanzoni and Giuseppe Remuzzi
      CJASN September 2007, 2 (5) 932-937; DOI: https://doi.org/10.2215/CJN.01180307

  6. Shahinian, Vahakn B.

    1. Comparison of Stage at Diagnosis of Cancer in Patients Who Are on Dialysis versus the General Population
      Shilpa Taneja, Sreedhar Mandayam, Zainab Z. Kayani, Yong-Fang Kuo and Vahakn B. Shahinian
      CJASN September 2007, 2 (5) 1008-1013; DOI: https://doi.org/10.2215/CJN.00310107

  7. Shaw, Leslie M.

    1. Therapeutic Drug Monitoring of Mycophenolic Acid
      Leslie M. Shaw, Michal Figurski, Michael C. Milone, Jennifer Trofe and Roy D. Bloom
      CJASN September 2007, 2 (5) 1062-1072; DOI: https://doi.org/10.2215/CJN.03861106

  8. Shihab, Fuad S.

    1. Do We Have a Pill for Renal Fibrosis?
      Fuad S. Shihab
      CJASN September 2007, 2 (5) 876-878; DOI: https://doi.org/10.2215/CJN.02660707

  9. Sinson, Grant P.

    1. Subdural Hematomas in Chronic Dialysis Patients: Significant and Increasing
      Puneet Sood, Grant P. Sinson and Eric P. Cohen
      CJASN September 2007, 2 (5) 956-959; DOI: https://doi.org/10.2215/CJN.03781106

  10. Smith, David C.

    1. Pirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis
      Monique E. Cho, David C. Smith, Mary H. Branton, Scott R. Penzak and Jeffrey B. Kopp
      CJASN September 2007, 2 (5) 906-913; DOI: https://doi.org/10.2215/CJN.01050207

  11. Smith, Jodi M.

    1. BK Virus Nephropathy in Pediatric Renal Transplant Recipients: An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry
      Jodi M. Smith, Vikas R. Dharnidharka, Lynya Talley, Karen Martz and Ruth A. McDonald
      CJASN September 2007, 2 (5) 1037-1042; DOI: https://doi.org/10.2215/CJN.04051206

  12. Smith, Kelly D.

    1. Spectrum of Renal Pathology in Hematopoietic Cell Transplantation: A Series of 20 Patients and Review of the Literature
      Anthony Chang, Sangeeta Hingorani, Jolanta Kowalewska, Mary E.D. Flowers, Tia Aneja, Kelly D. Smith, Shane M. Meehan, Roberto F. Nicosia and Charles E. Alpers
      CJASN September 2007, 2 (5) 1014-1023; DOI: https://doi.org/10.2215/CJN.01700407

  13. Sood, Puneet

    1. Subdural Hematomas in Chronic Dialysis Patients: Significant and Increasing
      Puneet Sood, Grant P. Sinson and Eric P. Cohen
      CJASN September 2007, 2 (5) 956-959; DOI: https://doi.org/10.2215/CJN.03781106

  14. Sosa, Marie Anne

    1. Single-Use versus Reusable Dialyzers: The Known Unknowns
      Ashish Upadhyay, Marie Anne Sosa and Bertrand L. Jaber
      CJASN September 2007, 2 (5) 1079-1086; DOI: https://doi.org/10.2215/CJN.01040207

  15. Sosnov, Jonathan

    1. Role of Mycophenolate Mofetil in the Treatment of Lupus Nephritis
      Gabriel Contreras and Jonathan Sosnov
      CJASN September 2007, 2 (5) 879-882; DOI: https://doi.org/10.2215/CJN.02740707

  16. Stenvinkel, Peter

    1. Plasma Pentraxin 3 in Patients with Chronic Kidney Disease: Associations with Renal Function, Protein-Energy Wasting, Cardiovascular Disease, and Mortality
      Mengli Tong, Juan Jesús Carrero, A. Rashid Qureshi, Björn Anderstam, Olof Heimbürger, Peter Bárány, Jonas Axelsson, Anders Alvestrand, Peter Stenvinkel, Bengt Lindholm and Mohamed E. Suliman
      CJASN September 2007, 2 (5) 889-897; DOI: https://doi.org/10.2215/CJN.00870207

  17. Strippoli, Giovanni F.M.

    1. Identifying Patients at Risk for Microalbuminuria via Interaction of the Components of the Metabolic Syndrome: A Cross-Sectional Analytic Study
      Monica Franciosi, Fabio Pellegrini, Michele Sacco, Giorgia De Berardis, Maria C.E. Rossi, Giovanni F.M. Strippoli, Maurizio Belfiglio, Gianni Tognoni, Miriam Valentini, Antonio Nicolucci and ; on behalf of the IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group
      CJASN September 2007, 2 (5) 984-991; DOI: https://doi.org/10.2215/CJN.01190307

  18. Suliman, Mohamed E.

    1. Plasma Pentraxin 3 in Patients with Chronic Kidney Disease: Associations with Renal Function, Protein-Energy Wasting, Cardiovascular Disease, and Mortality
      Mengli Tong, Juan Jesús Carrero, A. Rashid Qureshi, Björn Anderstam, Olof Heimbürger, Peter Bárány, Jonas Axelsson, Anders Alvestrand, Peter Stenvinkel, Bengt Lindholm and Mohamed E. Suliman
      CJASN September 2007, 2 (5) 889-897; DOI: https://doi.org/10.2215/CJN.00870207

T

  1. Talley, Lynya

    1. BK Virus Nephropathy in Pediatric Renal Transplant Recipients: An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry
      Jodi M. Smith, Vikas R. Dharnidharka, Lynya Talley, Karen Martz and Ruth A. McDonald
      CJASN September 2007, 2 (5) 1037-1042; DOI: https://doi.org/10.2215/CJN.04051206

  2. Taneja, Shilpa

    1. Comparison of Stage at Diagnosis of Cancer in Patients Who Are on Dialysis versus the General Population
      Shilpa Taneja, Sreedhar Mandayam, Zainab Z. Kayani, Yong-Fang Kuo and Vahakn B. Shahinian
      CJASN September 2007, 2 (5) 1008-1013; DOI: https://doi.org/10.2215/CJN.00310107

  3. Tirino, Giuseppina

    1. Stability of Target Hemoglobin Levels during the First Year of Epoetin Treatment in Patients with Chronic Kidney Disease
      Luca De Nicola, Giuseppe Conte, Paolo Chiodini, Bruno Cianciaruso, Andrea Pota, Vincenzo Bellizzi, Giuseppina Tirino, Deborah Avino, Fausta Catapano and Roberto Minutolo
      CJASN September 2007, 2 (5) 938-946; DOI: https://doi.org/10.2215/CJN.01690407

  4. Tognoni, Gianni

    1. Identifying Patients at Risk for Microalbuminuria via Interaction of the Components of the Metabolic Syndrome: A Cross-Sectional Analytic Study
      Monica Franciosi, Fabio Pellegrini, Michele Sacco, Giorgia De Berardis, Maria C.E. Rossi, Giovanni F.M. Strippoli, Maurizio Belfiglio, Gianni Tognoni, Miriam Valentini, Antonio Nicolucci and ; on behalf of the IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group
      CJASN September 2007, 2 (5) 984-991; DOI: https://doi.org/10.2215/CJN.01190307

  5. Tonelli, Marcello

    1. Mycophenolate Mofetil for Induction Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis
      Michael Walsh, Matthew James, David Jayne, Marcello Tonelli, Braden J. Manns and Brenda R. Hemmelgarn
      CJASN September 2007, 2 (5) 968-975; DOI: https://doi.org/10.2215/CJN.01200307

  6. Tong, Mengli

    1. Plasma Pentraxin 3 in Patients with Chronic Kidney Disease: Associations with Renal Function, Protein-Energy Wasting, Cardiovascular Disease, and Mortality
      Mengli Tong, Juan Jesús Carrero, A. Rashid Qureshi, Björn Anderstam, Olof Heimbürger, Peter Bárány, Jonas Axelsson, Anders Alvestrand, Peter Stenvinkel, Bengt Lindholm and Mohamed E. Suliman
      CJASN September 2007, 2 (5) 889-897; DOI: https://doi.org/10.2215/CJN.00870207

  7. Trofe, Jennifer

    1. Therapeutic Drug Monitoring of Mycophenolic Acid
      Leslie M. Shaw, Michal Figurski, Michael C. Milone, Jennifer Trofe and Roy D. Bloom
      CJASN September 2007, 2 (5) 1062-1072; DOI: https://doi.org/10.2215/CJN.03861106

  8. Tumlin, James A.

    1. Idiopathic IgA Nephropathy: Pathogenesis, Histopathology, and Therapeutic Options
      James A. Tumlin, Michael P. Madaio and Randolph Hennigar
      CJASN September 2007, 2 (5) 1054-1061; DOI: https://doi.org/10.2215/CJN.04351206

U

  1. Unruh, Mark L.

    1. Renal Provider Recognition of Symptoms in Patients on Maintenance Hemodialysis
      Steven D. Weisbord, Linda F. Fried, Maria K. Mor, Abby L. Resnick, Mark L. Unruh, Paul M. Palevsky, David J. Levenson, Stephen H. Cooksey, Michael J. Fine, Paul L. Kimmel and Robert M. Arnold
      CJASN September 2007, 2 (5) 960-967; DOI: https://doi.org/10.2215/CJN.00990207

  2. Upadhyay, Ashish

    1. Single-Use versus Reusable Dialyzers: The Known Unknowns
      Ashish Upadhyay, Marie Anne Sosa and Bertrand L. Jaber
      CJASN September 2007, 2 (5) 1079-1086; DOI: https://doi.org/10.2215/CJN.01040207

V

  1. Valentini, Miriam

    1. Identifying Patients at Risk for Microalbuminuria via Interaction of the Components of the Metabolic Syndrome: A Cross-Sectional Analytic Study
      Monica Franciosi, Fabio Pellegrini, Michele Sacco, Giorgia De Berardis, Maria C.E. Rossi, Giovanni F.M. Strippoli, Maurizio Belfiglio, Gianni Tognoni, Miriam Valentini, Antonio Nicolucci and ; on behalf of the IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group
      CJASN September 2007, 2 (5) 984-991; DOI: https://doi.org/10.2215/CJN.01190307

W

  1. Walsh, Michael

    1. Mycophenolate Mofetil for Induction Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis
      Michael Walsh, Matthew James, David Jayne, Marcello Tonelli, Braden J. Manns and Brenda R. Hemmelgarn
      CJASN September 2007, 2 (5) 968-975; DOI: https://doi.org/10.2215/CJN.01200307

  2. Weisbord, Steven D.

    1. Renal Provider Recognition of Symptoms in Patients on Maintenance Hemodialysis
      Steven D. Weisbord, Linda F. Fried, Maria K. Mor, Abby L. Resnick, Mark L. Unruh, Paul M. Palevsky, David J. Levenson, Stephen H. Cooksey, Michael J. Fine, Paul L. Kimmel and Robert M. Arnold
      CJASN September 2007, 2 (5) 960-967; DOI: https://doi.org/10.2215/CJN.00990207

  3. Wheeler, David C.

    1. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview
      Glenn M. Chertow, Lara B. Pupim, Geoffrey A. Block, Ricardo Correa-Rotter, Tilman B. Drueke, Jürgen Floege, William G. Goodman, Gerard M. London, Kenneth W. Mahaffey, Sharon M. Moe, David C. Wheeler, Moetaz Albizem, Kurt Olson, Preston Klassen and Patrick Parfrey
      CJASN September 2007, 2 (5) 898-905; DOI: https://doi.org/10.2215/CJN.04381206
Back to top

In this issue

View Selected Citations (0)